Khedera (Solution) Instructions for Use

Marketing Authorization Holder

Vita Line, LLC (Russia)

Manufactured By

Pharmtekhnologiya LLC (Republic of Belarus)

ATC Code

R05CA12 (Hederae Helix folia)

Active Substance

Hederae Helix folia (Grouping name)

Dosage Form

Khedera

Oral solution: 100 ml bottle with dosing syringe

Dosage Form, Packaging, and Composition

Oral solution slightly thick, yellow-brown in color with a characteristic anise odor.

* – is a mixture of the following composition: ivy leaf extract – 88.0%; maltodextrin – 10.0%; silicon dioxide – 2.0%.

Extraction solvent ethyl alcohol 30% (w/w)

Excipients : sorbitol solution (non-crystallizing), propylene glycol, glycerol, macrogolglycerol hydroxystearate, hydroxyethylcellulose, anise oil, hydrochloric acid and/or sodium hydroxide solution (to maintain pH level), purified water.

100 ml – bottles (1) together with a dosing syringe – cardboard packs with an insert.

Clinical-Pharmacological Group

Herbal expectorant

Pharmacotherapeutic Group

Drugs used for cough and colds; expectorants, excluding combinations with antitussives; expectorants

Pharmacological Action

Herbal medicine. It has an expectorant, mucolytic, and antispasmodic effect due to the presence of saponins.

Indications

As an expectorant in the complex therapy of infectious and inflammatory diseases of the respiratory tract, accompanied by cough with difficult-to-discharge sputum.

ICD codes

Dosage Regimen

Administer orally. Use the provided dosing syringe for accurate measurement.

Shake the bottle well before each use.

For adults and adolescents aged 12 years and older: take 2.5 ml of the solution three times daily.

For children aged 6 to 11 years: take 2.5 ml of the solution twice daily.

For children aged 2 to 5 years: take 1.25 ml of the solution three times daily.

For children under 2 years of age: use is not recommended due to lack of data.

Adhere to the maximum daily dose of 7.5 ml for adults and adolescents, 5 ml for children aged 6-11 years, and 3.75 ml for children aged 2-5 years.

Take the dose between meals for optimal absorption.

The duration of treatment depends on the clinical situation. Continue therapy for several days after symptom resolution.

If symptoms persist beyond 5-7 days of treatment, or if high fever, shortness of breath, or purulent sputum occurs, consult a physician.

Adverse Reactions

Possible allergic reactions, nausea, vomiting, diarrhea.

Rarely pain in the epigastric region.

Contraindications

Hypersensitivity to the drug; childhood – depending on the dosage form.

Use in Pregnancy and Lactation

Not recommended for use during pregnancy and lactation.

Pediatric Use

Use in children of appropriate age categories is possible according to indications, in recommended doses and dosage forms. It is necessary to strictly follow the instructions in the leaflets for ivy preparations regarding contraindications for the use of specific dosage forms of this drug in children of different ages.

Special Precautions

During treatment, it is recommended to consume a sufficient amount of warm fluids (water, tea, etc.).

If there is no effect after 5-7 days of treatment with the drug and/or if the condition worsens (appearance of asthma attacks, purulent sputum, fever), it is necessary to consult a doctor.

Drug Interactions

Should not be used simultaneously with antitussive drugs, as this impedes the discharge of liquefied sputum.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.